• AstraZeneca average price to free cash flow ratio for 2023 was 22.66, a 12.58% decline from 2022.
• AstraZeneca average price to free cash flow ratio for 2022 was 25.92, a 6.59% decline from 2021.
• AstraZeneca average price to free cash flow ratio for 2021 was 27.75, a 27.43% decline from 2020.

Price to free cash flow ratio can be defined as